• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

配体取代基对两种含8-羟基喹啉衍生物的新型铜(II)配合物细胞毒性活性的影响:通过MTT法和MCF-7癌细胞系(人乳腺癌)中的凋亡进行验证

Ligand substituent effect on the cytotoxicity activity of two new copper(ii) complexes bearing 8-hydroxyquinoline derivatives: validated by MTT assay and apoptosis in MCF-7 cancer cell line (human breast cancer).

作者信息

Ali Arif, Banerjee Somesh, Kamaal Saima, Usman Mohammad, Das Neeladrisingha, Afzal Mohd, Alarifi Abdullah, Sepay Nayim, Roy Partha, Ahmad Musheer

机构信息

Department of Applied Chemistry, ZHCET, Faculty of Engineering and Technology, Aligarh Muslim University Aligarh-202002 India

Molecular Endocrinology Laboratory, Department of Biotechnology, Indian Institute of Technology Roorkee Roorkee Uttarakhand-247667 India.

出版信息

RSC Adv. 2021 Apr 16;11(24):14362-14373. doi: 10.1039/d1ra00172h. eCollection 2021 Apr 15.

DOI:10.1039/d1ra00172h
PMID:35423979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8697721/
Abstract

In this study, we have examined the effect of ligand substituent on the structure-cytotoxicity relationships of the MCF-7 cancer cell line (human breast cancer), by two copper(ii) complexes {[Cu(qmbn)(Hqmba)(q)]·NO·2HO} (1) and {[Cu(Hqmba)(q)]·NO·2HO} (2) (where, qmbn = 2-(quinolin-8-yloxy)(methyl) benzonitrile (L1); Hqmba = 2-((quinolin-8-yloxy)methyl)benzoic acid (L2) and q = quinolin-8-olate). The structural analysis reveals that both the complexes exhibit distorted octahedral (CuNO) configuration which is further corroborated by density functional theory (DFT) calculations. The cytotoxicity impact of ligands (L1 and L2) and complexes (1 and 2) was screened against the MCF-7 cell line (human breast cancer). The MTT assay uptake indicated that the presence of -COOH functionality in complex 2 leads to higher cytotoxicity (lower IC) than that observed for complex 1 containing a -CN group. This could be due to the strong H-bonding forming propensity of the carboxylic acids. Incubation of MCF-7 cancer cells with IC concentrations of 1 and 2 promoted cellular detachments nuclear condensation and membrane destabilization followed by apoptosis as a result of metal-assisted generation of reactive oxygen species. Flow cytometry analysis showed that 1 and 2 might prompt early apoptosis in MCF-7 cells as the maximum percentage of cells appeared in the LR quadrant. Furthermore, mRNA expression analysis confirmed that both the complexes induced apoptosis in MCF-7 cells. Comparative mRNA expression analysis of complexes with their respective ligands also confirmed the enhanced apoptotic behavior of complexes. Furthermore, molecular docking studies of the complexes have also been performed with the active site of EGFR kinase receptors (major target for any cancer causing agent) due to similar analogues with FDA-approved EGFR inhibitors in order to rationalize its promising cytotoxicity activity.

摘要

在本研究中,我们通过两种铜(II)配合物{[Cu(qmbn)(Hqmba)(q)]·NO·2H₂O}(1)和{[Cu(Hqmba)(q)]·NO·2H₂O}(2)(其中,qmbn = 2-(喹啉-8-氧基)(甲基)苯甲腈(L1);Hqmba = 2-((喹啉-8-氧基)甲基)苯甲酸(L2)且q = 喹啉-8-醇盐)研究了配体取代基对MCF-7癌细胞系(人乳腺癌)结构-细胞毒性关系的影响。结构分析表明,这两种配合物均呈现扭曲的八面体(CuNO)构型,密度泛函理论(DFT)计算进一步证实了这一点。针对MCF-7细胞系(人乳腺癌)筛选了配体(L1和L2)及配合物(1和2)的细胞毒性影响。MTT法摄取表明,配合物2中-COOH官能团的存在导致其细胞毒性(更低的IC₅₀)高于含有-CN基团的配合物1。这可能是由于羧酸形成强氢键的倾向。用IC₅₀浓度的1和2孵育MCF-7癌细胞会促进细胞脱离、核浓缩和膜不稳定,随后由于金属辅助产生活性氧而导致细胞凋亡。流式细胞术分析表明,1和2可能促使MCF-7细胞早期凋亡,因为最大比例的细胞出现在LR象限。此外,mRNA表达分析证实这两种配合物均诱导MCF-7细胞凋亡。配合物与其各自配体的比较mRNA表达分析也证实了配合物增强的凋亡行为。此外,由于与FDA批准的EGFR抑制剂有相似类似物,还对配合物与EGFR激酶受体的活性位点(任何致癌剂的主要靶点)进行了分子对接研究,以阐明其有前景的细胞毒性活性的合理性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/76d457434fa7/d1ra00172h-f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/6d34bba4b3b4/d1ra00172h-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/2b6882c1feed/d1ra00172h-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/ce2071111f9d/d1ra00172h-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/4c7fe570c12b/d1ra00172h-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/862bd4a9815d/d1ra00172h-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/0b9d32687e73/d1ra00172h-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/379e7b461cf1/d1ra00172h-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/a6bc4ce0162d/d1ra00172h-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/91eb2e5ecd8b/d1ra00172h-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/0eb4e54aa158/d1ra00172h-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/628fe123eea7/d1ra00172h-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/ac457260f703/d1ra00172h-f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/edd800fc6b7a/d1ra00172h-f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/76d457434fa7/d1ra00172h-f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/6d34bba4b3b4/d1ra00172h-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/2b6882c1feed/d1ra00172h-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/ce2071111f9d/d1ra00172h-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/4c7fe570c12b/d1ra00172h-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/862bd4a9815d/d1ra00172h-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/0b9d32687e73/d1ra00172h-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/379e7b461cf1/d1ra00172h-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/a6bc4ce0162d/d1ra00172h-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/91eb2e5ecd8b/d1ra00172h-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/0eb4e54aa158/d1ra00172h-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/628fe123eea7/d1ra00172h-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/ac457260f703/d1ra00172h-f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/edd800fc6b7a/d1ra00172h-f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/647c/8697721/76d457434fa7/d1ra00172h-f13.jpg

相似文献

1
Ligand substituent effect on the cytotoxicity activity of two new copper(ii) complexes bearing 8-hydroxyquinoline derivatives: validated by MTT assay and apoptosis in MCF-7 cancer cell line (human breast cancer).配体取代基对两种含8-羟基喹啉衍生物的新型铜(II)配合物细胞毒性活性的影响:通过MTT法和MCF-7癌细胞系(人乳腺癌)中的凋亡进行验证
RSC Adv. 2021 Apr 16;11(24):14362-14373. doi: 10.1039/d1ra00172h. eCollection 2021 Apr 15.
2
Evaluation of catacholase mimicking activity and apoptosis in human colorectal carcinoma cell line by activating mitochondrial pathway of copper(II) complex coupled with 2-(quinolin-8-yloxy)(methyl)benzonitrile and 8-hydroxyquinoline.通过激活铜(II)配合物与 2-(8-喹啉氧基)(甲基)苯腈和 8-羟基喹啉的线粒体途径评价对人结直肠癌细胞系的拟酶活性和细胞凋亡的影响。
Bioorg Chem. 2021 Jan;106:104479. doi: 10.1016/j.bioorg.2020.104479. Epub 2020 Nov 21.
3
Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.采用 2,2'-联吡啶、氨基酸和一氧化氮衍生物的混合配体钌(II)配合物作为潜在抗癌药物提高乳腺癌细胞的细胞毒性。
Anticancer Agents Med Chem. 2021;21(12):1602-1611. doi: 10.2174/0929867327666201020155105.
4
Octahedral copper(ii)-diimine complexes of triethylenetetramine: effect of stereochemical fluxionality and ligand hydrophobicity on Cu/Cu redox, DNA binding and cleavage, cytotoxicity and apoptosis-inducing ability.三乙烯四胺八面体铜(II)-二亚胺配合物:立体化学动态和配体疏水性对 Cu/Cu 氧化还原、DNA 结合和切割、细胞毒性和诱导细胞凋亡能力的影响。
Dalton Trans. 2020 Jun 23;49(24):8282-8297. doi: 10.1039/d0dt00928h.
5
Novel mitochondria targeted copper(ii) complexes of ferrocenyl terpyridine and anticancer active 8-hydroxyquinolines showing remarkable cytotoxicity, DNA and protein binding affinity.新型线粒体靶向的二茂铁基三联吡啶和具有抗癌活性的 8-羟基喹啉铜(II)配合物,表现出显著的细胞毒性、DNA 和蛋白质结合亲和力。
Dalton Trans. 2017 Jan 3;46(2):396-409. doi: 10.1039/c6dt03660k.
6
Mixed ligand complexes of Co(II), Ni(II) and Cu(II) with quercetin and diimine ligands: synthesis, characterization, anti-cancer and anti-oxidant activity.槲皮素和二亚胺配体与 Co(II)、Ni(II) 和 Cu(II) 的混合配体配合物:合成、表征、抗癌和抗氧化活性。
J Biol Inorg Chem. 2020 Feb;25(1):161-177. doi: 10.1007/s00775-019-01749-z. Epub 2019 Dec 12.
7
Synthesis, structure information, DNA/BSA binding affinity and in vitro cytotoxic studies of mixed ligand copper(II) complexes containing a phenylalanine derivative and diimine co-ligands.含苯丙氨酸衍生物和二亚胺共配体的混合配体铜(II)配合物的合成、结构信息、DNA/牛血清白蛋白结合亲和力及体外细胞毒性研究
J Photochem Photobiol B. 2016 Jul;160:278-91. doi: 10.1016/j.jphotobiol.2016.04.021. Epub 2016 Apr 21.
8
Spectroscopy, electrochemistry and antiproliferative properties of Au(iii), Pt(ii) and Cu(ii) complexes bearing modified 2,2':6',2''-terpyridine ligands.含修饰 2,2':6',2''-三联吡啶配体的 Au(iii)、Pt(ii)和 Cu(ii)配合物的光谱、电化学和抗增殖性能。
Dalton Trans. 2018 May 8;47(18):6444-6463. doi: 10.1039/c8dt00558c.
9
Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity.设计用于增强抗癌活性的混合配体 Cu(II)腙配合物。
Eur J Med Chem. 2018 Aug 5;156:368-380. doi: 10.1016/j.ejmech.2018.07.022. Epub 2018 Jul 10.
10
Biological activity of mixed chelate copper(II) complexes, with substituted diimine and tridentate Schiff bases (NNO) and their hydrogenated derivatives as secondary ligands: Casiopeína's fourth generation.混合螯合铜(II)配合物的生物活性,其具有取代二亚胺和三齿席夫碱(NNO)及其氢化衍生物作为二级配体:卡舒平第四代
J Inorg Biochem. 2023 May;242:112097. doi: 10.1016/j.jinorgbio.2022.112097. Epub 2022 Dec 9.

引用本文的文献

1
In-vitro antiproliferative evaluation of newly synthesized titanium(IV) metallacyclic complexes on HeLa and MCF7 cell lines.新合成的钛(IV)金属环配合物对HeLa和MCF7细胞系的体外抗增殖评估
Sci Rep. 2025 Aug 8;15(1):29066. doi: 10.1038/s41598-025-13995-0.
2
Advanced synthesis, comprehensive characterization, and potent cytotoxicity of 2,6-Bis(2-aminophenylimino)methyl)-4-methoxyphenol and its binuclear copper(II) complex.2,6-双(2-氨基苯基亚氨基)甲基)-4-甲氧基苯酚及其双核铜(II)配合物的高级合成、全面表征和强大细胞毒性
Sci Rep. 2025 Feb 26;15(1):6957. doi: 10.1038/s41598-025-89381-7.
3
Multifaceted Characterization and Therapeutic Evaluation of Co-precipitated Cobalt Ferrite Nanoparticles for Magnetic Hyperthermia Cancer Therapy.

本文引用的文献

1
Copper complexes as prospective anticancer agents: and evaluation, selective targeting of cancer cells by DNA damage and S phase arrest.铜配合物作为潜在的抗癌剂:通过DNA损伤和S期阻滞对癌细胞进行评估和选择性靶向。
RSC Adv. 2018 May 9;8(30):16973-16990. doi: 10.1039/c8ra00954f. eCollection 2018 May 3.
2
Recent advances in the synthesis of biologically and pharmaceutically active quinoline and its analogues: a review.生物及药用活性喹啉及其类似物合成的最新进展:综述
RSC Adv. 2020 Jun 2;10(35):20784-20793. doi: 10.1039/d0ra03763j. eCollection 2020 May 27.
3
Therapeutic potential of dithiocarbamate supported gold compounds.
用于磁热疗癌症治疗的共沉淀钴铁氧体纳米粒子的多方面表征与治疗评估
J Med Phys. 2024 Oct-Dec;49(4):510-518. doi: 10.4103/jmp.jmp_57_24. Epub 2024 Dec 18.
4
studies, synthesis, characterization and studies of levosulpiride derivatives.左舒必利衍生物的研究、合成、表征及相关研究
Future Med Chem. 2024;16(23):2459-2473. doi: 10.1080/17568919.2024.2408213. Epub 2024 Oct 15.
5
Synthesis of quercetin derivatives as cytotoxic against breast cancer MCF-7 cell line and studies.槲皮素衍生物的合成及其对乳腺癌 MCF-7 细胞系的细胞毒性研究。
Future Med Chem. 2024;16(17):1749-1759. doi: 10.1080/17568919.2024.2379241. Epub 2024 Aug 5.
6
Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes.基于8-羟基喹啉腙铜(II)配合物的有前景的抗癌剂。
Front Chem. 2023 Mar 21;11:1106349. doi: 10.3389/fchem.2023.1106349. eCollection 2023.
7
Investigations on Anticancer Potentials by DNA Binding and Cytotoxicity Studies for Newly Synthesized and Characterized Imidazolidine and Thiazolidine-Based Isatin Derivatives.新型合成并具有特征的咪唑烷和噻唑烷基于色酮衍生物的 DNA 结合和细胞毒性研究的抗癌潜力研究。
Molecules. 2022 Jan 6;27(2):354. doi: 10.3390/molecules27020354.
二硫代氨基甲酸盐负载金化合物的治疗潜力
RSC Adv. 2020 Jan 16;10(5):2975-2988. doi: 10.1039/c9ra09682e. eCollection 2020 Jan 14.
4
Molecular designing, crystal structure determination and in silico screening of copper(II) complexes bearing 8-hydroxyquinoline derivatives as anti-COVID-19.基于 8-羟基喹啉衍生物的铜(II)配合物的分子设计、晶体结构测定及计算机虚拟筛选抗 COVID-19 活性
Bioorg Chem. 2021 May;110:104772. doi: 10.1016/j.bioorg.2021.104772. Epub 2021 Feb 24.
5
Evaluation of catacholase mimicking activity and apoptosis in human colorectal carcinoma cell line by activating mitochondrial pathway of copper(II) complex coupled with 2-(quinolin-8-yloxy)(methyl)benzonitrile and 8-hydroxyquinoline.通过激活铜(II)配合物与 2-(8-喹啉氧基)(甲基)苯腈和 8-羟基喹啉的线粒体途径评价对人结直肠癌细胞系的拟酶活性和细胞凋亡的影响。
Bioorg Chem. 2021 Jan;106:104479. doi: 10.1016/j.bioorg.2020.104479. Epub 2020 Nov 21.
6
In vitro antiproliferative effect of vanadium complexes bearing 8-hydroxyquinoline-based ligands - the substituent effect.基于 8-羟基喹啉的钒配合物的体外抗增殖作用 - 取代基效应。
Dalton Trans. 2020 May 26;49(20):6596-6606. doi: 10.1039/d0dt01017k.
7
In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological target.三齿硫代缩氨基脲铜配合物的体外和体内抗癌活性:揭示一个未被探索的药理学靶点。
Eur J Med Chem. 2020 May 15;194:112266. doi: 10.1016/j.ejmech.2020.112266. Epub 2020 Mar 24.
8
Optically pure chiral copper(II) complexes of rosin derivative as attractive anticancer agents with potential anti-metastatic and anti-angiogenic activities.松香衍生物的光学纯手性铜(II)配合物作为有吸引力的抗癌剂,具有潜在的抗转移和抗血管生成活性。
Eur J Med Chem. 2019 Aug 15;176:175-186. doi: 10.1016/j.ejmech.2019.05.030. Epub 2019 May 14.
9
New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity.新型喹啉/查尔酮杂合体作为抗癌剂:细胞毒性和 PI3K 抑制活性的设计、合成和评价。
Bioorg Chem. 2019 Feb;82:360-377. doi: 10.1016/j.bioorg.2018.10.064. Epub 2018 Nov 2.
10
Analysis of Cell Viability by the MTT Assay.通过MTT法分析细胞活力。
Cold Spring Harb Protoc. 2018 Jun 1;2018(6):2018/6/pdb.prot095505. doi: 10.1101/pdb.prot095505.